nimodipine and ozagrel
nimodipine has been researched along with ozagrel in 4 studies
Research
Studies (4)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cook, DA; Tsuji, T | 1 |
| Asano, T; Hidaka, H; Ikegaki, I; Satoh, S; Shibuya, M; Suzuki, Y | 1 |
| Asano, T; Hitomi, A; Ikegaki, I; Satoh, S; Shibuya, M; Suzuki, Y | 1 |
Other Studies
4 other study(ies) available for nimodipine and ozagrel
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Biphasic response to substance P in canine basilar arteries.
Topics: Animals; Basilar Artery; Benzoquinones; Dogs; Endothelium, Vascular; Female; In Vitro Techniques; Indomethacin; Lipoxygenase Inhibitors; Male; Methacrylates; Nimodipine; Oxyhemoglobins; Saponins; Substance P; Thromboxane-A Synthase; Vasoconstriction; Vasodilation | 1992 |
Neuroprotective properties of a protein kinase inhibitor against ischaemia-induced neuronal damage in rats and gerbils.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Body Water; Brain Chemistry; Brain Ischemia; Calcium Channel Blockers; Cell Death; Embolism; Enzyme Inhibitors; Gerbillinae; Male; Methacrylates; Neurons; Neuroprotective Agents; Nimodipine; Protein Kinase Inhibitors; Rats; Thromboxane-A Synthase | 1996 |
Hemorheological abnormalities in experimental cerebral ischemia and effects of protein kinase inhibitor on blood fluidity.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Arterial Occlusive Diseases; Blood Viscosity; Calcium Channel Blockers; Dose-Response Relationship, Drug; Enzyme Inhibitors; Erythrocytes; Hematocrit; Hemodilution; Ischemic Attack, Transient; Male; Methacrylates; Middle Cerebral Artery; Nimodipine; Protein Kinase Inhibitors; Rats; Rats, Wistar; Thromboxane-A Synthase | 2000 |